Published in Clin Exp Rheumatol on October 02, 1996
A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene (1992) 3.48
Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med (1995) 2.75
Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS (1996) 2.41
Microarray application in prenatal diagnosis: a position statement from the cytogenetics working group of the Italian Society of Human Genetics (SIGU), November 2011. Ultrasound Obstet Gynecol (2012) 2.38
Quantitative PCR and RT-PCR in virology. PCR Methods Appl (1993) 2.20
Pregnancy outcome following maternal exposure to statins: a multicentre prospective study. BJOG (2012) 2.14
High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study. Teratology (1999) 2.12
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet (2000) 2.12
Evaluation of prenatal ultrasound diagnosis of fetal abdominal wall defects by 19 European registries. Ultrasound Obstet Gynecol (2001) 2.10
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. Arch Intern Med (1997) 1.92
Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J Clin Microbiol (1992) 1.85
Temozolomide as salvage treatment in primary brain lymphomas. Br J Cancer (2007) 1.81
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J Virol (1992) 1.80
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol (2000) 1.79
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol (2001) 1.73
Clinical and morphological features of kidney involvement in primary Sjögren's syndrome. Nephrol Dial Transplant (2001) 1.67
Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet (1997) 1.65
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J Virol (2000) 1.64
Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease. Neurology (2007) 1.61
Recombination hotspot in NF1 microdeletion patients. Hum Mol Genet (2001) 1.61
Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B. Proc Natl Acad Sci U S A (1990) 1.54
Anti-cardiolipin antibodies in autoimmune thyroid diseases. Clin Endocrinol (Oxf) (1994) 1.53
Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J Invest Dermatol (1999) 1.50
Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am J Med Genet A (2009) 1.49
Prenatal detection of congenital renal malformations by fetal ultrasonographic examination: an analysis of 709,030 births in 12 European countries. Eur J Med Genet (2005) 1.45
How wide is the clinical spectrum of the acrocallosal syndrome? Report of a mild case. J Med Genet (1990) 1.44
Molecular analysis of uromodulin and SAH genes, positional candidates for autosomal dominant medullary cystic kidney disease linked to 16p12. J Nephrol (2001) 1.43
Complement receptor (CR1) and IgG or IgA on erythrocytes and in circulating immune complexes in patients with glomerulonephritis. Nephrol Dial Transplant (1989) 1.42
Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. Blood (1997) 1.41
Granulocytopenia after combined therapy with interferon and angiotensin-converting enzyme inhibitors: evidence for a synergistic hematologic toxicity. Am J Med (1995) 1.40
Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1. Hum Mol Genet (2000) 1.38
Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1. Proc Natl Acad Sci U S A (2003) 1.38
Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. J Virol (1997) 1.35
Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol (1995) 1.33
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet (1999) 1.32
Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol (2001) 1.32
Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Eur J Immunol (1994) 1.32
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS (1997) 1.32
The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. Eur J Immunol (1993) 1.27
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo. J Virol (1996) 1.27
Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome. Ann Rheum Dis (2004) 1.26
Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction. J Med Virol (1991) 1.26
Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters. Infect Immun (1999) 1.25
Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. Ultrasound Obstet Gynecol (2001) 1.25
Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2. J Med Genet (2004) 1.25
Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection. Curr Pharm Des (2002) 1.24
Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci U S A (1996) 1.23
Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments. Hepatology (1998) 1.21
Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J Virol (2001) 1.19
Genetic diversity of Streptococcus suis clinical isolates from pigs and humans in Italy (2003-2007). Euro Surveill (2009) 1.19
Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA). Clin Exp Immunol (2000) 1.18
Evaluation of the prenatal diagnosis of limb reduction deficiencies. EUROSCAN Study Group. Prenat Diagn (2000) 1.17
Adverse effects of prenatal methimazole exposure. Teratology (2001) 1.17
Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds. J Clin Microbiol (1995) 1.16
Long-term chikungunya infection clinical manifestations after an outbreak in Italy: a prognostic cohort study. J Infect (2012) 1.16
Flexibility of melting temperature assay for rapid detection of insertions, deletions, and single-point mutations of the AGXT gene responsible for type 1 primary hyperoxaluria. Clin Chem (2000) 1.15
Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology (1997) 1.15
Periodic ZnO nanorod arrays defined by polystyrene microsphere self-assembled monolayers. Nano Lett (2006) 1.14
Identification of hepatitis B virus core protein regions exposed or internalized at the surface of HBcAg particles by scanning with monoclonal antibodies. Virology (1994) 1.14
Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. Clin Rheumatol (1998) 1.13
Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent. Clin Exp Immunol (1983) 1.13
Evolution of hypervariable region 1 of hepatitis C virus in primary infection. J Virol (1998) 1.13
Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions. Hum Mutat (1999) 1.13
Radiologic study of 42 cases of Wilson disease. Skeletal Radiol (1985) 1.13
Quantitation of hepatitis C virus genome molecules in plasma samples. J Clin Microbiol (1994) 1.12
Situational analysis of varying models of adherence support and loss to follow up rates; findings from 27 treatment facilities in eight resource limited countries. Trop Med Int Health (2010) 1.12
Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure. Nephrol Dial Transplant (1996) 1.12
Omphalocele and gastroschisis: a collaborative study of five Italian congenital malformation registries. Teratology (1993) 1.11
Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real-time polymerase chain reaction study. Eur J Clin Microbiol Infect Dis (2008) 1.10
NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes. Am J Hum Genet (2000) 1.09
Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus. J Appl Microbiol (2007) 1.09
Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C. J Hepatol (2001) 1.09
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. Virology (2001) 1.08
Familial clustering of IgA nephropathy: further evidence in an Italian population. Am J Kidney Dis (1999) 1.06
Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. Virology (1993) 1.04
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. J Virol (1994) 1.04
Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution. J Virol (1999) 1.04
Evaluation of the prenatal diagnosis of neural tube defects by fetal ultrasonographic examination in different centres across Europe. J Med Screen (2000) 1.03
Phytochemical and antiinflammatory studies on Terminalia catappa. Fitoterapia (2004) 1.03
Diverse prevalence of large deletions within the OA1 gene in ocular albinism type 1 patients from Europe and North America. Hum Genet (2001) 1.03
Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection. Virology (1999) 1.03
Effects of a gluten-free diet in primary IgA nephropathy. Clin Nephrol (1990) 1.03
Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy. Maturitas (2005) 1.03
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum. Hepatology (1997) 1.02